| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/30/2013 | CN102906095A Pyrrolopyrazine derivatives as SYK and JAK inhibitors |
| 01/30/2013 | CN102905762A Methods and compositions for inducing satiety |
| 01/30/2013 | CN102905720A New uses of oxytocin-like molecules and related methods |
| 01/30/2013 | CN102905715A Composition comprising coumestrol or bean extract containing coumestrol |
| 01/30/2013 | CN102899288A Method for constructing human islet-derived pancreatic stem cell line and method for differentiation of human islet-derived pancreatic stem cell line into insulin-producing cells |
| 01/30/2013 | CN102899276A Streptococcus thermophilus capable of lowering cholesterol levels and application thereof |
| 01/30/2013 | CN102899231A Deficiency-tonifying and cold-dispelling traditional Chinese medicine health wine and preparation method thereof |
| 01/30/2013 | CN102898426A Pyrazolopyridine derivatives for inhibiting activity of insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase |
| 01/30/2013 | CN102898400A GPR119 agonist and application thereof |
| 01/30/2013 | CN102898378A Phthalazinone derivatives and application thereof |
| 01/30/2013 | CN102898371A Chiral polycyclic piperidine derivative, synthetic method and application |
| 01/30/2013 | CN102898362A Preparation method and applications of derivatives containing nicotinic acids and acetylsalicylic acid curcumin |
| 01/30/2013 | CN102898355A N-substituted Fagomine derivative and synthesizing method and applications thereof |
| 01/30/2013 | CN102898332A Hydroxamic acid derivative, its pharmaceutical composition, preparation method and application |
| 01/30/2013 | CN102898317A Organic amino compounds serving as immunopotentiators, metabolic enhancers or roborants and preparation method and use thereof |
| 01/30/2013 | CN102898284A 3-allyl-[1,1'-biphenyl]-4-phenol, derivatives, preparation methods and uses thereof |
| 01/30/2013 | CN102895676A New application of P53 gene |
| 01/30/2013 | CN102895673A Treatment of eye disorders |
| 01/30/2013 | CN102895650A Application of cyclotides ingredients in zizyphus jujube roots |
| 01/30/2013 | CN102895648A Clinical nutrition emulsion and preparation method thereof |
| 01/30/2013 | CN102895626A Preparation technology and production method for integrated new formulation of radix bupleuri decoction minus pinellia ternate plus snakegourd root |
| 01/30/2013 | CN102895624A Preparation technology and production method for integrated new formulation of Hou's Black Powder |
| 01/30/2013 | CN102895621A Preparation technology and production method for integrated new formulation of turtle shell decocted pill |
| 01/30/2013 | CN102895617A Preparation technology and production method for integrated new formulation of bighead atractylodes rhizome and monkshood decoction |
| 01/30/2013 | CN102895567A Chinese herbal medicine for treating diabetes and complications thereof |
| 01/30/2013 | CN102895538A Preparation technology and production method for integrated new formulation of white tiger and genseng decoction |
| 01/30/2013 | CN102895537A Medicine treating diabetes |
| 01/30/2013 | CN102895492A Drug for treating hyperlipidaemia |
| 01/30/2013 | CN102895457A Preparation technology and production method for integrated new formulation of golden chamber kidney qi pill |
| 01/30/2013 | CN102895400A Traditional Chinese medical decoction for treatment of diabetic constipation of the elderly |
| 01/30/2013 | CN102895397A Method for processing prepared rehmannia root, and product and application thereof |
| 01/30/2013 | CN102895364A Chinese medicinal active ingredient with effect of treating diabetes mellitus |
| 01/30/2013 | CN102895349A Traditional Chinese medicine tea for treating hypertension, hyperlipidemia and hyperglycemia |
| 01/30/2013 | CN102895342A Medicinal composition for preventing or/and treating diabetes mellitus and application of medicinal composition |
| 01/30/2013 | CN102895314A Medicine with weight-reducing and lipid-lowering functions |
| 01/30/2013 | CN102895301A Improved preparation technology of xylitol pills |
| 01/30/2013 | CN102895300A Traditional Chinese medicine compound capsule for reducing blood sugar, blood fat and blood pressure and preparation method thereof |
| 01/30/2013 | CN102895290A Preparation technology and production method for integrated new formulation of snakegourd root and oyster powder |
| 01/30/2013 | CN102895270A Application of composition of red yeast rice and ginkgo leaves in aspect of controlling diabetic complications |
| 01/30/2013 | CN102895268A Lipid-lowering composition |
| 01/30/2013 | CN102895246A Preparation method of in vivo glycation level-improving dementia animal model |
| 01/30/2013 | CN102895235A Application of charantadiol A in preparation of drugs treating diabetes |
| 01/30/2013 | CN102895226A Application of Aphanamixoid A in medicines for reducing blood sugar |
| 01/30/2013 | CN102895208A Coated tablet formulation and method |
| 01/30/2013 | CN102895204A Sevelamer carbonate crude drug for preparing tablets, preparation method and application thereof |
| 01/30/2013 | CN102895189A Gingerol liposome and preparation method thereof |
| 01/30/2013 | CN102895134A Slimming warm-up oil |
| 01/30/2013 | CN102228637B Hpyerglycemic mulberry latex lyophilized powder capsule and preparation method thereof |
| 01/30/2013 | CN102172397B In vivo targeting of dendritic cells |
| 01/30/2013 | CN102151284B Composition containing fucoidin sulfate and application thereof |
| 01/30/2013 | CN102000124B Ginkgo biloba extract oral liquid and preparation method thereof |
| 01/30/2013 | CN101933922B Amino acid composition containing new antioxidant |
| 01/30/2013 | CN101896477B The five crystal forms of the nicousamide, the preparation methods, the pharmaceutical compositions and the uses thereof |
| 01/30/2013 | CN101879165B Novel antihypertensive medicament compound preparation |
| 01/30/2013 | CN101642466B Preparation method of composition containing pilose antler polysaccharides and having function of reducing blood lipids |
| 01/30/2013 | CN101613271B 3-alkoxyl-6-carboxyl rhein or officinal salt thereof and preparation method and application thereof |
| 01/30/2013 | CN101543489B Compounds as liver X receptor modifier |
| 01/30/2013 | CN101321525B Heteroaryl substituted piperidine derivatives as L-CPT1 inhibitors |
| 01/30/2013 | CN101316838B 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as h3 modulators |
| 01/29/2013 | US8362297 High protein supplement |
| 01/29/2013 | US8362248 Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| 01/29/2013 | US8362049 Urea glucokinase activators |
| 01/29/2013 | US8362034 Quinoline compound, and composition containing centipede extract or compounds isolated therefrom for prevention and treatment of cardiovascular disease |
| 01/29/2013 | US8362010 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor |
| 01/29/2013 | US8362008 Amido-thiophene compounds and their use as 11-beta-HSD1 inhibitors |
| 01/29/2013 | US8361972 Pharmaceutical formulations containing an SGLT2 inhibitor |
| 01/29/2013 | US8361968 Metastin derivatives and use thereof |
| 01/29/2013 | US8361960 Periostin-induced pancreatic regeneration |
| 01/29/2013 | CA2731378C Therapeutic or prophylactic agent for diabetes, obesity, dyslipidemia or metabolic syndrome, comprising benzylamine derivative or pharmaceutically acceptable acid addition salt thereof |
| 01/29/2013 | CA2570673C Compounds and methods for treating dyslipidemia |
| 01/29/2013 | CA2569459C Glucagon receptor antagonists, preparation and therapeutic uses |
| 01/29/2013 | CA2507987C A vegetable composition having blood enhancing properties |
| 01/29/2013 | CA2460000C Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 01/24/2013 | WO2013013052A1 Substituted xanthine derivatives |
| 01/24/2013 | WO2013013042A1 Botulinum toxins for use in a method for treatment of adipose deposits |
| 01/24/2013 | WO2013013029A1 Anti-clta4, anti-glut2 protein for the treatment of type 1 diabetes |
| 01/24/2013 | WO2013012827A1 Diaminocyclohexane compounds and uses thereof |
| 01/24/2013 | WO2013012644A1 2-methylene-20(21)-dehydro-19,24,25,26,27,-pentanor-vitamin d analogs |
| 01/24/2013 | WO2013011932A1 Azabenzimidazole derivative having ampk-activating activity |
| 01/24/2013 | WO2013011402A1 Gpr 119 modulators |
| 01/24/2013 | WO2013011285A1 Azetidine derivatives for treatment of melanin related disorders |
| 01/24/2013 | WO2013011098A1 Imino-sugar c-glycosides, preparation and use thereof |
| 01/24/2013 | WO2013011033A1 3-(fluorvinyl)pyrazoles and the use thereof |
| 01/24/2013 | WO2013010862A1 Fungicidal alkyl-substituted 2-[2-chloro-4-(4-chloro-phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds |
| 01/24/2013 | WO2013010780A1 Pharmaceutical composition for treating a metabolic syndrome |
| 01/24/2013 | WO2013010380A1 Btk inhibitors |
| 01/24/2013 | WO2012151252A3 Composition and method for treatment of diabetes |
| 01/24/2013 | WO2012148246A3 A preparation method of sitagliptin |
| 01/24/2013 | WO2012021287A9 Methods for the treatment and prevention of metabolic disorders |
| 01/24/2013 | US20130023586 Use of tricyclic sesquiterpene lactones in the treatment of obesity and related diseases and non-therapeutic treatable conditions |
| 01/24/2013 | US20130023584 Theaflavin Compositions, Related Processes and Methods of Use |
| 01/24/2013 | US20130023583 Theaflavin Compositions, Related Processes and Methods of Use |
| 01/24/2013 | US20130023579 Modulation of angiopoietin-like 3 expression |
| 01/24/2013 | US20130023560 Methods and compositions for the treatment of iron toxicity |
| 01/24/2013 | US20130023558 CARBOXYLIC ACID DERIVATIVES HAVING AN OXAZOLO[4,5-c]PYRIDINE RING |
| 01/24/2013 | US20130023538 Heteroaryl Derivatives as CFTR Modulators |
| 01/24/2013 | US20130023537 Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/24/2013 | US20130023535 Method of preventing and/or treating diabetic neuropathy |
| 01/24/2013 | US20130023530 Novel nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in nk-3 receptors mediated disorders |
| 01/24/2013 | US20130023527 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |